Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'FLUOROURACIL FAILURE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 87 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Biasco, G; Gallerani, E
      Treatment of liver metastases from colorectal cancer: what is the best approach today?

      DIGESTIVE AND LIVER DISEASE
    2. Minami, H; Fujii, H; Igarashi, T; Itoh, K; Tamanoi, K; Oguma, T; Sasaki, Y
      Phase I and pharmacological study of a new camptothecin derivative, exatecan mesylate (DX-8951f), infused over 30 minutes every three weeks

      CLINICAL CANCER RESEARCH
    3. Zonder, JA; Shields, AF; Zalupski, M; Chaplen, R; Heilbrun, LK; Arlauskas, P; Philip, PA
      A phase II trial of bryostatin 1 in the treatment of metastatic colorectalcancer

      CLINICAL CANCER RESEARCH
    4. Maindrault-Goebel, F; de Gramont, A; Louvet, C; Andre, T; Carola, E; Mabro, M; Artru, P; Gilles, V; Lotz, JP; Izrael, V; Krulik, M
      High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7)

      EUROPEAN JOURNAL OF CANCER
    5. Cunningham, D; James, RD
      Integrating the oral fluoropyrimidines into the management of advanced colorectal cancer

      EUROPEAN JOURNAL OF CANCER
    6. Alonso, V; Escudero, P; Zorrilla, M; Isla, MD; Herrero, A; Mayordomo, JI; Martinez-Trufero, J; Saenz, A; Tres, A; Anton, A
      Phase I trial of weekly irinotecan combined with UFT as second-line treatment for advanced colorectal cancer

      EUROPEAN JOURNAL OF CANCER
    7. Guichard, S; Arnould, S; Hennebelle, I; Bugat, R; Canal, P
      Combination of oxaliplatin and irinotecan on human colon cancer cell lines: activity in vitro and in vivo

      ANTI-CANCER DRUGS
    8. Ong, SYK; Clarke, SJ; Bishop, J; Dodds, HM; Rivory, LP
      Toxicity of irinotecan (CPT-11) and hepato-renal dysfunction

      ANTI-CANCER DRUGS
    9. Ulrich-Pur, H; Kornek, GV; Fiebiger, W; Gedlicka, C; Raderer, M; Lenauer, A; Depisch, D; Lang, F; Pidlich, J; Scheithauer, W
      Multicenter phase II trial of dose-fractionated irinotecan in patients with advanced colorectal cancer failing oxaliplatin-based first-line combination chemotherapy

      ANNALS OF ONCOLOGY
    10. Scheithauer, W; Kornek, GV; Schuell, B; Ulrich-Pur, H; Penz, M; Raderer, M; Lang, F; Schneeweiss, B; Lenauer, A; Depisch, D
      Second-line treatment with oxaliplatin plus raltitrexed in patients with advanced colorectal cancer failing fluoropyrimidine/leucovorin-based chemotherapy

      ANNALS OF ONCOLOGY
    11. Grumett, SA; Archer, VR; Midgley, R; Mulholland, P; Nicum, S; Blewitt, L; Kerr, DJ
      The role of mitomycin C in the treatment of patients with advanced colorectal cancer resistant to 5-fluorouracil-folinic acid chemotherapy

      ANNALS OF ONCOLOGY
    12. Bonetti, A; Zaninelli, M; Leone, R; Franceschi, T; Fraccon, AP; Pasini, F; Sabbioni, R; Cetto, GL; Sich, D; Brienza, S; Howell, SB
      Use of the ratio of time to progression following first- and second-line therapy to document the activity of the combination of oxaliplatin with 5-fluorouracil in the treatment of colorectal carcinoma

      ANNALS OF ONCOLOGY
    13. Rothenberg, ML; Kuhn, JG; Schaaf, LJ; Rodriguez, GI; Eckhardt, SG; Villalona-Calero, MA; Rinaldi, DA; Hammond, LA; Hodges, S; Sharma, A; Elfring, GL; Petit, RG; Locker, PK; Miller, LL; von Hoff, DD
      Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks

      ANNALS OF ONCOLOGY
    14. Khayat, D; Gil-Delgado, M; Antoine, EC; Nizri, D; Bastian, G
      The role of irinotecan and oxaliplatin in the treatment of advanced colorectal cancer

      ONCOLOGY-NEW YORK
    15. Sun, WJ; Haller, DG
      The role of irinotecan and oxaliplatin in the treatment of advanced colorectal cancer - The Khayat et al article reviewed

      ONCOLOGY-NEW YORK
    16. Haller, DG
      Update on chemotherapy for advanced colorectal cancer

      ONCOLOGY-NEW YORK
    17. Beretta, GD; Pessi, MA; Poletti, P; Mosconi, S; Labianca, R
      New drugs and combinations in the palliative treatment of colon and rectalcancer

      EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
    18. Royce, ME; Hoff, PM; Dumas, P; Lassere, Y; Lee, JJ; Coyle, J; Ducharme, MP; De Jager, R; Pazdur, R
      Phase I and pharmacokinetic study of exatecan mesylate (DX-8951f): A novelcamptothecin analog

      JOURNAL OF CLINICAL ONCOLOGY
    19. Reimer, P; Ruckle-Lanz, H
      New therapeutic options in the chemotherapy of advanced colorectal cancer

      MEDIZINISCHE KLINIK
    20. Louvet, C
      New chemotherapies for colorectal cancer treatment

      GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    21. Shigeoka, Y; Itoh, K; Igarashi, T; Ishizawa, K; Saeki, T; Fujii, H; Minami, H; Imoto, S; Sasaki, Y
      Clinical effect of irinotecan in advanced and metastatic breast cancer patients previously treated with doxorubicin- and docetaxel-containing regimens

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    22. Lokich, J
      Phase I clinical trial of weekly combined topotecan and irinotecan

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    23. Lima, CMSR; Urbanic, JJ; Lal, A; Kneuper-Hall, R; Brunson, CY; Green, MR
      Beyond pancreatic cancer: Irinotecan and gemcitabine in solid tumors and hematologic malignancies

      SEMINARS IN ONCOLOGY
    24. Hanioka, N; Ozawa, S; Jinno, H; Ando, M; Saito, Y; Sawada, J
      Human liver UDP-glucuronosyltransferase isoforms involved in the glucuronidation of 7-ethyl-10-hydroxycamptothecin

      XENOBIOTICA
    25. Kakolyris, S; Souglakos, J; Kouroussis, C; Androulakis, N; Mavroudis, D; Kalbakis, K; Kotsakis, A; Vardakis, N; Koukourakis, M; Romanos, J; Georgoulias, V
      A dose-finding study of irinotecan (CPT-11) plus a four-day continuous 5-fluorouracil infusion in advanced colorectal cancer

      ONCOLOGY
    26. Comella, P; Biglietto, M; Casaretti, R; De Luica, L; Avallone, A; Maiorino, L; Di Lullo, L; De Cataldis, G; Rivellini, F; Comella, G
      Irinotecan and mitomycin C in 5-fluorouracil-refractory colorectal cancer patients - A phase I/II study of the Southern Italy Cooperative Oncology Group

      ONCOLOGY
    27. Takeda, Y; Kobayashi, K; Akiyama, Y; Soma, T; Handa, S; Kudoh, S; Kudo, K
      Prevention of irinotecan (CPT-11)-induced diarrhea by oral alkalization combined with control of defecation in cancer patients

      INTERNATIONAL JOURNAL OF CANCER
    28. Garufi, G; Dogliotti, L; D'Attino, RM; Tampellini, M; Aschelter, AM; Pugliese, P; Perrone, M; Nistico, C; Comis, S; Terzoli, E
      Irinotecan and chronomodulated infusion of 5-fluorouracil and folinic acidin the treatment of patients with advanced colorectal carcinoma - A phase I study

      CANCER
    29. Chau, I; Webb, A; Cunningham, D; Hill, M; Waters, JS; Norman, A; Massey, A
      Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer

      BRITISH JOURNAL OF CANCER
    30. Sobrero, A; Guglielmi, A; Cirillo, M; Recaldin, E; Frassineti, GL; Aschele, C; Ravaioli, A; Testore, P; Caroti, C; Gallo, L; Pessi, MA; Cortesi, E; Turci, D; Grossi, F; Labianca, R
      5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highlyeffective, low cost chemotherapy for advanced colorectal cancer

      BRITISH JOURNAL OF CANCER
    31. Waters, J; Cunningham, D
      The changing face of chemotherapy in colorectal cancer

      BRITISH JOURNAL OF CANCER
    32. Royce, ME; Hoff, PM; Pazdur, R
      Progress in colorectal cancer chemotherapy - How far have we come, how farto go?

      DRUGS & AGING
    33. Kehrer, DFS; Yamamoto, W; Verweij, J; de Jonge, MJA; de Bruijn, P; Sparreboom, A
      Factors involved in prolongation of the terminal disposition phase of SN-38: Clinical and experimental studies

      CLINICAL CANCER RESEARCH
    34. Pitot, HC; Goldberg, RM; Reid, JM; Sloan, JA; Skaff, PA; Erlichman, C; Rubin, J; Burch, PA; Adjei, AA; Alberts, SA; Schaaf, LJ; Elfring, G; Miller, LL
      Phase I dose-finding and pharmacokinetic trial of irinotecan hydrochloride(CPT-11) using a once-every-three-week dosing schedule for patients with advanced solid tumor malignancy

      CLINICAL CANCER RESEARCH
    35. van Groeningen, CJ; Van der Vijgh, WJF; Baars, JJ; Stieltjes, H; Huibregtse, K; Pinedo, HM
      Altered pharmacokinetics and metabolism of CPT-11 in liver dysfunction: A need for guidelines

      CLINICAL CANCER RESEARCH
    36. Sobrero, A; Kerr, D; Glimelius, B; Van Cutsem, E; Milano, G; Pritchard, DM; Rougier, P; Aapro, M
      New directions in the treatment of colorectal cancer: a look to the future

      EUROPEAN JOURNAL OF CANCER
    37. Massacesi, C; Norman, A; Price, T; Hill, M; Ross, P; Cunningham, D
      A clinical nomogram for predicting long-term survival in advanced colorectal cancer

      EUROPEAN JOURNAL OF CANCER
    38. Madarnas, Y; Webster, P; Shorter, AM; Bjarnason, GA
      Irinotecan-associated pulmonary toxicity

      ANTI-CANCER DRUGS
    39. Hennebelle, I; Terret, C; Chatelut, E; Bugat, R; Canal, P; Guichard, S
      Characterization of CPT-11 converting carboxylesterase activity in colon tumor and normal tissues: comparison with p-nitra-phenylacetate converting carboxylesterase activity

      ANTI-CANCER DRUGS
    40. Gornet, JM; Azoulay, D; Levi, F; Yovine, A; Misset, JL; Goldwasser, F
      Dramatic tumor response of bulky liver metastases following treatment withCPT-11 and a chronomodulated 4-day infusion of 5-fluorouracil, folinic acid and oxaliplatin every 2 weeks in a colorectal cancer patient

      ANTI-CANCER DRUGS
    41. van Riel, JMGH; van Groeningen, CJ
      Palliative chemotherapy in advanced gastrointestinal cancer

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    42. Kaneki, T; Koizumi, T; Kawashima, A; Tsushima, K; Kubo, K; Fujimoto, K; Honda, T; Akamatsu, T
      Double cancer (lung and colon cancer) that showed complete remission with irinotecan and cisplatin combined chemotherapy

      JOURNAL OF GASTROENTEROLOGY
    43. Punt, CJA
      'Hold the Mayo': Solid facts or pulp fiction?

      ANNALS OF ONCOLOGY
    44. Maiello, E; Gebbia, V; Giuliani, F; Paoletti, G; Gebbia, N; Cigolari, S; Fortunato, S; Pedicini, T; Borsellino, N; Lopez, M; Colucci, G
      5-fluorouracil and folinic acid with or without CPT-11 in advanced colorectal cancer patients: A multicenter randomised phase II study of the Southern Italy Oncology Group

      ANNALS OF ONCOLOGY
    45. Chester, JD; Dent, JT; Wilson, G; Ride, E; Seymour, MT
      Protracted infusional 5-fluorouracil (5-FU) with bolus mitomycin in 5-FU-resistant colorectal cancer

      ANNALS OF ONCOLOGY
    46. Sobrero, A; Zaniboni, A; Frassineti, GL; Aschele, C; Guglielmi, A; Giuliani, R; Ravaioli, A; Lanfranco, C; Caroti, C; Arnoldi, E; Barni, S; Gallo, L; Pessi, MA; Turci, D; Cortesi, E; Grossi, F; Frontini, L; Piazza, E; Bruzzi, P; Labianca, R
      Schedule specific biochemical modulation of 5-fluorouracil in advanced colorectal cancer: A randomized study

      ANNALS OF ONCOLOGY
    47. Goldwasser, F; Gross-Goupil, M; Tigaud, JM; Di Palma, M; Marceau-Suissa, J; Wasserman, E; Yovine, A; Misset, JL; Cvitkovic, E
      Dose escalation of CPT-11 in combination with oxaliplatin using an every two weeks schedule: A phase I study in advanced gastrointestinal cancer patients

      ANNALS OF ONCOLOGY
    48. Wilke, H; Stahl, M
      Colorectal cancer and metastasectomy: treatment of advanced disease

      ANNALS OF ONCOLOGY
    49. Royce, ME; Medgyesy, D; Zukowski, TH; Dwivedy, S; Hoff, PM; Pazdur, R
      Colorectal cancer: Chemotherapy treatment overview

      ONCOLOGY-NEW YORK
    50. Mitchell, EP
      Irinotecan in preoperative combined-modality therapy for locally advanced rectal cancer

      ONCOLOGY-NEW YORK
    51. Govindarajan, R
      Irinotecan and thalidomide in metastatic colorectal cancer

      ONCOLOGY-NEW YORK
    52. Hoff, PM
      Novel therapeutic approaches for metastatic colorectal cancer

      ONCOLOGY-NEW YORK
    53. Schraub, S; Mercier, M; Arveux, P
      Quality of life assessment in cancerology

      PRESSE MEDICALE
    54. Napier, MP; Ledermann, JA
      Novel chemotherapeutic agents in colorectal cancer

      EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
    55. Dawson, LA; McGinn, CJ; Normolle, D; Ten Haken, RK; Walker, S; Ensminger, W; Lawrence, TS
      Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies

      JOURNAL OF CLINICAL ONCOLOGY
    56. de Jonge, MJA; Sparreboom, A; Planting, AST; van der Burg, MEL; de Boer-Dennert, MM; ter Steeg, J; Jacques, C; Verweij, J
      Phase I study of 3-week schedule of irinotecan combined with cisplatin in patients with advanced solid tumors

      JOURNAL OF CLINICAL ONCOLOGY
    57. Bokemeyer, C
      Irinotecan - Clinical progress in the second-line therapy of advanced colorectal cancer

      ONKOLOGIE
    58. Wilke, H; Vanhoefer, U; Achterrath, W; Stahl, M
      Irinotecan: New results in the combination chemotherapy of colorectal cancer

      ONKOLOGIE
    59. Jager, E; Jager, D; Orth, J; Knuth, A
      Irinotecan in second-line therapy of metastatic colorectal cancer

      ONKOLOGIE
    60. Mosconi, S; Cascinu, S; Zaniboni, A; Catalano, V; Giordani, P; Beretta, GD; Martignoni, G; Pancera, G; Baldelli, AM; Poletti, P; Curti, C; Labianca, R
      The value of oxaliplatin in combination with continuous infusion +/- bolus5-fluorouracil and levo-folinic acid in metastatic colorectal cancer progressing after 5FU-based chemotherapy: A GISCAD (Italian Group for the Study of Digestive Tract) cancer phase II trial

      TUMORI
    61. Bonetti, A
      New treatment approaches for advanced colorectal cancer

      TUMORI
    62. Rougier, P; Mitry, E
      Current treatment options for advanced colorectal cancer

      SEMINARS IN ONCOLOGY
    63. Sumpter, K; Cunningham, D
      Combination chemotherapy and colorectal cancer

      SEMINARS IN ONCOLOGY
    64. Rougier, P; Mitry, E
      Colorectal cancer chemotherapy: Irinotecan

      SEMINARS IN ONCOLOGY
    65. Tsunoda, T; Tanimura, H; Hotta, T; Tani, M; Iwahashi, M; Ishimoto, K; Tanaka, H; Matsuda, K; Yamaue, H
      In vitro augmentation of antitumor effect in combination with CPT-11 and CDDP for human colorectal cancer

      JOURNAL OF SURGICAL ONCOLOGY
    66. Graeven, U; Schmiegel, W
      Colon cancer - Consensus of therapeutic strategies

      INTERNIST
    67. Boland, CR; Sinicrope, FA; Brenner, DE; Carethers, JM
      Colorectal cancer prevention and treatment

      GASTROENTEROLOGY
    68. Ellenberg, SS; Temple, R
      Placebo-controlled trials and active-control trials in the evaluation of new treatments - Part 2: Practical issues and specific cases

      ANNALS OF INTERNAL MEDICINE
    69. Wein, A; Riedel, C; Hanke, B; Lampert, S; Bruckl, W; Reingruber, B; Hohenberger, W; Hahn, EG
      Improvements in the palliative treatment of colorectal carcinoma

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    70. Henry, B; Becouarn, Y; Aussage, P
      Clinical benefits of stabilisation with second line chemotherapy in patients with metastatic colorectal cancer

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    71. Maindrault-Goebel, F; Louvet, C; Andre, T; Carola, E; Lotz, JP; Molitor, JL; Garcia, ML; Gilles-Amar, V; Izrael, V; Krulik, M; de Gramont, A
      Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6)

      EUROPEAN JOURNAL OF CANCER
    72. Andre, T; Louvet, C; Maindrault-Goebel, F; Couteau, C; Mabro, M; Lotz, JP; Gilles-Amar, V; Krulik, M; Carola, E; Izrael, V; de Gramont, A
      CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer

      EUROPEAN JOURNAL OF CANCER
    73. Bleiberg, H
      CPT-11 in gastrointestinal cancer

      EUROPEAN JOURNAL OF CANCER
    74. Iveson, TJ; Hickish, T; Schmitt, C; Van Cutsem, E
      Irinotecan in second-line treatment of metastatic colorectal cancer: Improved survival and cost-effect compared with infusional 5-FU

      EUROPEAN JOURNAL OF CANCER
    75. Daniele, B
      Should chemotherapy be used as a treatment of advanced colorectal carcinoma (ACC) in patients over 70 years of age? Pro

      EUROPEAN JOURNAL OF CANCER
    76. Van Cutsem, E
      Raltitrexed (Tomudex (TM)) in combination treatment for colorectal cancer:New perspectives

      EUROPEAN JOURNAL OF CANCER
    77. Georgoulias, V; Crown, JP
      Increasing options in cancer therapy: current status and future prospects

      ANTI-CANCER DRUGS
    78. Armand, JP; Cunningham, D; van Cutsem, E; Misset, JL; Kohne, CH
      Clinical advances with topoisomerase I inhibitors in gastrointestinal malignancies

      ANTI-CANCER DRUGS
    79. Koehne, CH; Midgley, R; Seymour, M; Kerr, DJ
      Advanced colorectal cancer: Which regimes should we recommend?

      ANNALS OF ONCOLOGY
    80. Hoff, PM; Pazdur, R
      Oxaliplatin and UFT/oral calcium folinate for advanced colorectal carcinoma

      ONCOLOGY-NEW YORK
    81. Desch, CE; Benson, AB; Smith, TJ; Flynn, PJ; Krause, C; Loprinzi, CL; Minsky, BD; Petrelli, NJ; Pfister, DG; Somerfield, MR
      Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology

      JOURNAL OF CLINICAL ONCOLOGY
    82. Conroy, T; Rauch, P; Guillemin, F
      Quality of life in patients with colorectal cancer

      GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    83. Conroy, T; Paillot, B; Adenis, A
      New drugs in gastrointestinal oncology. Current status and future directions

      GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    84. Erlichman, C; Goldberg, RM; Pitot, HC; O'Connell, MJ
      Optimum doses of irinotecan

      LANCET
    85. Rothenberg, ML; Blanke, CD
      Topoisomerase I inhibitors in the treatment of colorectal cancer

      SEMINARS IN ONCOLOGY
    86. Adjei, AA; Argiris, A; Murren, JR
      Docetaxel and irinotecan, alone and in combination, in the treatment of non-small cell lung cancer

      SEMINARS IN ONCOLOGY
    87. Garcia, IS; Rueda, A; Alba, E
      Irinotecan-induced central nervous system toxicity: a case report

      JOURNAL OF THE NATIONAL CANCER INSTITUTE


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 03/06/20 alle ore 22:31:36